HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Protocol for inducing infliximab tolerance in a patient with psoriatic spondylarthritis].

AuthorsR Gallardo, M J Fobelo, C Pastor, J C Orta-Cuevas
JournalFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (Farm Hosp) 2010 Mar-Apr Vol. 34 Issue 2 Pg. 94-6 ISSN: 1130-6343 [Print] Spain
Vernacular TitleProtocolo de inducción de tolerancia a infliximab en paciente con espondilartropatía psoriásica.
PMID20304368 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Histamine H1 Antagonists
  • Immunologic Factors
  • Tumor Necrosis Factor-alpha
  • dexchlorpheniramine
  • Chlorpheniramine
  • Infliximab
  • Methylprednisolone
Topics
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (administration & dosage, adverse effects, therapeutic use)
  • Arthritis, Psoriatic (drug therapy)
  • Chlorpheniramine (therapeutic use)
  • Desensitization, Immunologic
  • Drug Administration Schedule
  • Flushing (chemically induced, prevention & control)
  • Histamine H1 Antagonists (therapeutic use)
  • Humans
  • Immunologic Factors (administration & dosage, adverse effects, therapeutic use)
  • Infliximab
  • Infusions, Intravenous
  • Male
  • Methylprednisolone (therapeutic use)
  • Premedication
  • Spondylarthritis (drug therapy)
  • Sweating (drug effects)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)
  • Vomiting (chemically induced, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: